Vaginal Cuff Brachytherapy Fractionation Study
Phase 3 Recruiting
258 enrolled
SCOUT-1
Recruiting
750 enrolled
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Phase 3 Recruiting
360 enrolled
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Phase 2 Recruiting
165 enrolled
ANALLISA
Phase 2 Recruiting
30 enrolled
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Phase 1 Recruiting
258 enrolled
A Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX43 (Anti-PD-L1 ADC) in Patients With Advanced Gynecological Malignant Tumors
Phase 2 Recruiting
190 enrolled
A Study of PHST001 in Advanced Solid Tumors
Phase 1 Recruiting
272 enrolled
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Phase 3 Recruiting
336 enrolled
OCTOPOD-IP
Phase 1 Recruiting
18 enrolled
A Randomized Controlled Trial Evaluating the Feasibility and Preliminary Efficacy of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in Advanced Epithelial Ovarian Cancer
Phase NA Recruiting
60 enrolled
ENVISION
Recruiting
4,200 enrolled
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Phase 2 Recruiting
81 enrolled
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Phase 2 Recruiting
2,900 enrolled
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Phase 1 Recruiting
20 enrolled
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
150 enrolled
DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer
Phase 1 Recruiting
30 enrolled
mNav
Phase NA Recruiting
288 enrolled
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Phase 3 Recruiting
255 enrolled
EZHiSWITCH
Phase 2 Recruiting
900 enrolled
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Phase 1 Recruiting
138 enrolled
Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
Phase 2 Recruiting
25 enrolled
Ph 2 Elacestrant in ER Positive Uterine Sarcomas
Phase 2 Recruiting
30 enrolled
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Phase 1 Recruiting
63 enrolled
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Phase 2 Recruiting
285 enrolled
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 Recruiting
1,006 enrolled
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 Recruiting
714 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
124 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
A Study of SHR-A1811 in Subjects With Ovarian Cancer
Phase 3 Recruiting
300 enrolled
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 Recruiting
100 enrolled
A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)
Phase 3 Recruiting
384 enrolled
TROY
Phase 2 Recruiting
116 enrolled
EPOCA
Recruiting
50 enrolled
A Clinical Study of the Safety and Effectiveness of an Investigational Cell Therapy Given With and Without an Investigational RNA-based Vaccine in Patients With Organ Tumors
Phase 1 Recruiting
214 enrolled
ECHO
Recruiting
3,110 enrolled
PAROLA
Phase 3 Recruiting
510 enrolled
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
Recruiting
2,000 enrolled
TroFuse-020
Phase 3 Recruiting
686 enrolled
TroFuse-033
Phase 3 Recruiting
1,123 enrolled
A Study of LY4175408 in Participants With Advanced Cancer
Phase 1 Recruiting
240 enrolled
OMNIRAY
Phase 1 Recruiting
421 enrolled
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
Phase 1/2 Recruiting
245 enrolled
FiREBOLT
Phase 1 Recruiting
241 enrolled
FRAmework-01
Phase 3 Recruiting
1,080 enrolled
TroFuse-036
Phase 3 Recruiting
1,023 enrolled
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
Phase NA Recruiting
8,000 enrolled
NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer
Phase 1 Recruiting
24 enrolled
Secondary Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Recurrent Mucinous Ovarian Cancer (HI-MOC Study)
Phase 2 Recruiting
30 enrolled
HOTT
Phase 3 Recruiting
220 enrolled